TAIWAN · TWSE / TPEx
CVC
皇將 · 4744 · TPEx (OTC) · Biotech and medical
Share price, 2026-10-19NT$26.601 month -3.1% · 1 year -3.3%
Directors and supervisors hold5,798,48110.2% of shares issued
Of which pledged0.0%0
Revenue, 2026-09-14.6%year on year
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 佶恆實業股份有限公司 | Chairman | 1,636,000 | 2,225,000 | 3.91% | — | — |
| 林益裕 | Chairman (corporate representative) · President | — | 553,000 | 0.97% | — | — |
| 蔡明宏 | Vice chairman | 1,560,000 | 1,649,000 | 2.90% | — | — |
| 德鑫投資股份有限公司 | Director | 2,027,481 | 1,924,481 | 3.38% | — | — |
| 顏禎葳 | Director (corporate representative) | — | 0 | — | — | — |
| 盧陽正 | Independent director | — | 0 | — | — | — |
| 洪朝成 | Independent director | — | 0 | — | — | — |
| 楊世豪 | Vice president | — | 199,937 | 0.35% | — | 1,000 |
| 何銘烈 | Vice president | — | 1,888 | 0.00% | — | 53 |
| 張晉嘉 | Chief financial officer | — | 630 | 0.00% | — | — |